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This study concerns 11 patients with immune complex 
associated cutaneous vasculitis (5 leukocytoclastic vas-
culitis or Gougerot Ruiter's disease, 3 essential mixed 
cryoglobulinaemia, 2 Henoch-Schonlein purpura and 1 
W aldenstrom's hypergammaglobulinaemic purpura). By 
determining the clearance of 5 'Cr-labeled IgG sen sitized 
erythrocytes we showed a slight modification in the 
splenic mononuclear phagocyte system. In patients with 
Gougerot-Ruiter's disease the clearance of the autolo-
gous IgG-coated erythrocytes was delayed in 1 patient, 
and normal in 2 patients. In contrast, the 8 other patients 
showed accelerated rates of IgG-mediated clearance. 
There was no statistically significant correlation be-
tween clearance rate, serum complement component 
levels and composition and/or levels of circulating im-
mune complexes. Thus, the accelerated clearance rate 
suggests an enhanced activity of the mononuclear phag-
ocyte system IgG-Fc receptors. 
Formation of immune complexes is a normal part of the 
immune defense leading to the elimination and neutralization 
of solu ble antigens. The antigen-antibody complexes are then 
quickly removed from the circulation by phagocytosis either by 
direct interaction of immune complexes (IC) with the Fe recep-
tors or by indirect interaction with complement receptors. 
Certain IC are particularly pathogenic because of their a bility 
to persist in circulation and play a major role in initiating tissue 
damage. Certain similarities between experimental animal 
models of vasculitis [1,2] and human vasculitis [3] have been 
noted, such as demonstration of immunoglobulins and comple-
ment at -the site of t issue damage [ 4]. Therefore it becomes 
evident that circulating IC (CIC) are implicated in the patho-
genesis of vasculitis [5,6]. It has been shown that the elimination 
rate ofiC depends on the activity ofthe mononuclear phagocyte 
system (MPS), since a saturated MPS may enable IC to remain 
circulating longer and thereby localize in abnormal sites [7]. 
R ecently Frank and his co-workers [8] have described tech-
niques which evaluate the functional activity of splenic MPS 
membrane receptors for the Fe portion of IgG. They reported 
that patients with systemic lupus erythematosus (SLE) had a 
marked defect in Fe receptor functional activity which corre-
lated with disease activity and with the presence of CIC [8). 
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P atients with Sjogren's syndrome (SS) also had a marked defect 
in Fe receptor functional activity that conelated with wide-
spread disease [9]. In cutaneous vasculitis, we postulated that 
similar defect could be responsable for allowing IC to continue 
to circulate predisposing to tissue deposition. 
In the present work, we investigated the clearance of IC 
formed by IgG-coated erythrocytes in patients with leukocyto-
clastic vasculitis or Gougerot-Ruiter's disease, essential mixed 
cryoglobulinaemia, Henoch-Schonlein purpma and Walden-
strom's hypergammaglobulinemic purpma. All these differen t 
groups of vasculitis were associated with high levels of CIC. 
The results of this study showed no evident defect in the 
clearance of such complexes. However the composition of IC 
and in particular the class of the antibody moiety appeared to 
have an influence on the functional activity of the spleen 
mononuclear cells. 
MATERIALS AND METHODS 
Patient Selection 
The subjects who participated in th is study were chosen from inpa-
tients in our hospital. 
E leven pa tients were classified according to a clear-cut clinical and 
his topathological description of necrotizing vasculitides [10]: Gougerot 
Ruiter's disease (leukocytoclastic vasculi tis or hypersensitivity angiitis 
(5 cases), essentia l mixed cryoglobulinaemia (3 cases), H enoch-Schon-
lein purpura (2 cases), Waldenstrom's hypergammaglobulinemic pw·-
pura (1 case). Only pa tients wi th a Rhesus-positive blood type were 
selected . None of the patients was on therapy with systemic cortico-
steroids. Three of the 11 patients were receiving chlorambucil. The 
details of the diagnosis and the most relevan t clinical and histological 
data are summarized in T able l. 
Controls 
T en healthy volunteers, 5 males and 5 females between ages 22 and 
45 yr (mean age of 30) were studied in the same manner as the patients. 
A pool of 80 normal human sera from volunteers were used as controls 
in the detection of circulating immune complexes using polyethylene 
glycol (PEG). 
Prep aration. of l gG anti-Rh (D) Antibody 
194 
Antiserum, obt{lined from individual donors, with Rh(D) specificity 
(Centre R egional de Transfusion Sanguine de Lyon-Besnost) was pu-
rified by sequential ammonium sulfate precipitation and Sephadex G-
200 gel filtration. The lgG anti Rh (D) preparation was sterilized by 
fil t ration. The fil t rate was shown to be s terile and pyrogen free by 
Centre Regional de Tranfusion Sanguine de Lyon-Besnost. The speci-
ficity and the t itre of the antibody were determined by Centre de 
Transfusion Sanguine, Pavillon H, Hopital Edouard Herriot. 
Preparation and Clearance Measurement o("'Cr- labeled !gO-coated 
Erythrocytes 
Clearance of IgG ant i R h (D) coated autologous eryth1·ocytes was 
used to test the functional activity of the IgG-Fc receptors on splenic 
mononuclear phagocytes. This clearance study was performed accord-
ing to the method of Frank et a l [8]. 
On the day of the study, 2.5 ml of blood was drawn and mixed with 
0.5 ml of acid citrate dextrose solu tion. The mixture was centrifuged at 
500 g for 10 min, the supernatant and the buffy coat were removed. 
The packed cells were incubated with 30 J.LCi of Na5 'Cr (CR5l-S.l , 
CEA, Gif-sur-Yvette, FRANCE) at 37°C for 15 min. The 51Cr-eryth-
rocytes were washed 3 times in sterile physiological saline. The packed 
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r ed cells were then incubated for 1 hr at 37°C with a solution of lgG 
a n ti-D at a concentration of 25 (Lg/ ml. After inc ubation the cells we re 
washed 4 times in s te ril e saline, and 1 ml of packed cells was exactly 
m easured and diluted in an appropriate volume in order to keep the 
sam e red cell concentration as the patient's blood and reinjected in to 
a n antecubital vein. The lgG-coated 51Cr-la beled erythrocy te survival 
was d etermined by t imed serial blood samples. 
A 5 ml sample of blood was withdrawn at 3, 10, 20, 40, and 60 min 
after the end of t he re injection. The radioactivity of two 2 ml blood 
samples was measured in a gamma counter (Packard Gamma Scintil-
lation s pectometer , M odel 5375). The erythrocyte survival was calcu-
lated as recommended by the International Committee for Standard i-
zation in Hematology. Erythrocyte clearance was expressed as t he ha lf-
life of the cells which is the time in which 50 percent of t he ce lls were 
removed from the circulation. 
Quantitation of the number of antibody molecules per erythrocyte 
The number of IgG anti-Rh (D) antibody molecules bound per 
erythrocyte was determined by measuring the uptake of 12"1-labeled 
anti-Rh (D) antibody. 1 mg of immunoglobulin solution in phosphate 
buffered saline 0.15 M pH 7.2 was labeled with 500 (LCi 1251 (IMS 30, 
Radioche mical Centre, Amersham) by adding 60 (Lg chloramine T. 
After 2 min incuba tion at room temperature, 120 (Lg sodium metabisul-
fite was added to stop the reaction. Free iodine was removed on a 
Sephadex G25 column. 
The determination of antibody molecules bound per erythrocyte was 
perform ed under the standard conditions described in "Prepru·ation 
and c learance measurement of ''1Cr-labeled lgG-coated erythrocytes." 
Erythrocytes were collected from 10 normal subjects. At the ''1Cr -
la b e ling step, er ythrocytes were incubated for 15 min at 37°C with 
physiologicalc saline instea~ of 01Cr-solu tion. The red cells were sensi-
t ized with "·'!-la beled antibody. After 1 hr, a t 37°C, the cells were 
wash ed 4 times in s terile saline then incuba ted with auto logous serum 
for 30 miJ1 in order to reduce nonspecific cellular binding. The eryth-
rocytes we re washed twice in saline and the radioactivity o f the packed 
cells de te rmined in a Packru·d Gamma Scintillation spectometer. Cell-
associated l gG was extrapolated from IgG concentrat ion and converted 
to molecules per cell because t he red cell concentration was known. 
The moleculru· weight of IgG was assumed to be 160,000 daltons in 
t hese calculations . 
Circulating immune complexes 
The IC in the sera of patients and con trols were determined us ing 
t he technique of Kazatchkine et a l (11]. 
Soluble complexes were precipitated with a 2% solu t ion of PEG, mol. 
wt. 6,000 daltons. 0.5 ml vol were mixed with 0.1 ml of 12% PEG in 
bru·b itone-buffered saline conta ining 60 mM EDTA, pH 7.6 and left for 
18 hr at +4°C. The precipitate was separated from t he serum by 
centrifuging at 1000 g for 20 min at +4°C, and washed once in 2 ml of 
2% PEG in barbitone-buffered saline con ta ining 10 mM EDTA. The 
tubes were drained and the precipitates dissolved in 0.5 ml of bru·bitone-
buffered saline. The fraction of t he total C1"' IgG and lgM which had 
been precipi tated was measured by the method of Mancini. The results 
were expressed as a percentage of the precipitated l gG, lgM and C 1" 
a nd compared with sera from 10 normal volunteers included in t he 
same experiment. The results were compa red with t he mean and 
standru·d deviation (SD) obtained with a pool of sera from 80 normal 
subjects. Va lues of precipitated IgG, IgM a nd C1" from the test samples 
which were more t ha n 2 SD a bove the mean values obtained in t he 
normal sera we re regarded as posit ive. 
The presence or a bsence of IgA in the precipitate was shown by 
double diffusion aga inst monospecific an t iserum (lower limi t of sensi-
tivity 31 J.Lg/ml). 
All the patient sera were also tested by radioimmunoassay with 
radioiodinated C1" for immune complexes. The C1., binding test was 
performed by Dr. Lamelin, Instit ut Pasteur, Lyon. 
Other serological studies 
Tota l complement activity (CHr,o) was measured according to Mayer 
(12]. Serum C1"' C3, C4, facto r B, l gG, IgM , and lgA concen trations 
were measured by single radial immunodiffusion using monospecific 
a nt ise ra. Levels of complement were considered abnormal when t hey 
deviated by mor e tha n 2 SD from the norma l human sera. Rheumatoid 
factor was assayed by a latex fixation test (13]. 
TABLE I. Clinical features and histological data of the selected p atients with cutaneous vasculitis 
Case No. 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
A ge 
58 
60 
61 
70 
46 
75 
48 
62 
45 
58 
15 
Sex 
F 
M 
F 
M 
M 
F 
F 
M 
F 
F 
F 
Clinical features 
N ecrotizing vasculitis with palpable purpura a nd 
hemorraghic vesicles over the lower extr emit ies. 
Arthralgia wi th fever. Microscopic hematuria but 
normal renal function. Biopsy revealed a fibrino id 
necrosis of the vessel walls with fibrin thrombi. 
Necrotizing vasculitis. History of streptococcal infection. 
Severe cutaneous and systemic vasculitis (ru·thri t is, 
hemat uria, serious abdominal involvement) which 
failed to respond to treatment. Impaired rena l function 
with endo and extra -membra nous proliferative 
glomerulonephritis of a poststrep tococcal type. 
N ecrotizing vasculitis. Impa ired rena l function. History of 
bronchial infection. 
Necro tizing vasculitis. Normal renal function. 
Arthralgia, fever, several ulcerated a reas over lower 
extremities. Cryoglobulins:IgG and IgM. Patient on 
Chlorambucil therapy. 
Cryoglobulins:IgG and lgM. Patient on Chlorambucil 
therapy. 
Cryoglobulins:IgG, IgM a nd IgA. Lymphoproliferative 
neoplasia. Patient on Chlorambucil therapy. 
Waldenstrom's hypergammaglobulinemic purpura wi th 
elevated gamma globulins (polyclona l IgG > 30 g/ 1) . 
Norma l bone marrow biopsy. Light typical 
leukocytoclastic vasculitis. 
Arthralgia with fever. Normal renal function. 
Arthralgia with fever. Normal renal function. 
Diagnosis 
Histological criteria for t he d iagnostic 
of leukocytoclastic vasculi t is 
(Gougerot-Ruiter's disease) 
-Involvement of small vesse ls in the 
dermis with: 
· E ndothelia l swelling 
·Perivascular leukocytic 
· Infiltration 
· Leukocytoclas is 
· Extravasation of red blood cells 
·Necrosis of blood vesse l walls 
Cri teria for essen tia l mixed 
cryoglobulinaemia: 
-Purpura with cold precipi tating 
proteins in sera (IgM, lgG or lgA) 
without well defined connective 
t issue disease 
- Vasculru· lesions compru·able with 
leukocytoclastic vasculitis 
Waldenstrom's hyperglobulinaemic 
purpura 
Criteria for Henoch-Schiinlein 
P urpura: 
- Acute purpuric eruption on lower 
extre mi ties 
-Art hrit is 
-Abdominal pain or/ and renal 
disease 
-Skin biopsy: le ucocytoclast ic 
vasculitis wit hout necrosis 
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M easurement of Radioactivity over Livers and Spleens in Clearing 
!gO-coated Radiochromated Erythrocytes 
The pa tient was in a horizontal position with his breas t to 2 external 
probes so tha t the probes viewed the liver and spleen. Immediately 
afte r the injection, data were recorded for a maximum of 60 min. Blood 
samples were also taken a t regular intervals for assessment of the half-
life clearance oflgG-coated radiochromated erythrocytes. The dynamic 
s tudy was la ter analyzed on a Hewlett Packard computer and results 
were expressed as the number of impulses per minute (corrected for 
physical characteristics of the computer). 
Statistical M ethods 
The half-life va lues of "'Cr-lgG-erythrocytes in patients and in 
cont rols were compared by the Student t-test. Correlations were per-
formed by t he nonparametric Spearman's rank correlation test. 
RESULTS 
Number of Antibody Molecules per Erythrocyte 
Since the site of the clearance of IgG-coated erythrocytes 
may varied with the amount of antibodies coating the cells 
[14], we determined the uptake of 125I-anti Rh (D) IgG under 
standard ·sensitization conditions. For 10 Rh-positive normal 
controls, the uptake was 1,977 ± 191 (mean ± SD) molecules 
per erythrocyte. No difference in the relative sensitization be-
tween normal subjects and 4 patients (case 1, 6, 9, and 10) was 
obse rved. One Rh-negative patient (not included in these re-
sults) demonstrated no erythrocyte clearance with use of anti 
Rh (D) IgG. 
51Cr-Labeled IgG-sensitized Erythrocyte Clearance 
At the level of sensitization, IgG-sensitized radiochromated 
erythrocytes underwent a single mono-exponential decline in 
the circulation during the first hour after their intravenous 
administration (Fig 1) . Several estimates of the mathematical 
equation representing the clearance curves of normal controls 
were tested. Clearance was considered as a simple mathematical 
type. The estimated equation "best" fitting the experimental 
points (correlation coefficient 0.9949) was assumed to be of the 
form y = a.e"' where y = relative cpm/rnl of blood, x = time 
(min .), b = 0.0171. 
The half-life of the labeled cells in normal volunteers was 39 
± 6 min. (mean± 95% confidence interval). None of the patients 
with Henoch-Schonlein purpura or essential mixed cryoglobu-
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FIG 1. "'Cr-labeled IgG-sensitized erythrocyte clearance in a group 
of 10 normal volunteers . . "'Cr-labe\ed lgG-sensitized erythrocytes un-
derwent a mono-exponential clearance in the circulation. The half-life 
(T l / 2) of the cells is the time in which 50 percent of the blood 
radioactivity disappeared from the circulation. Values· for relative ra-
dioactivity per ml of blood were expressed as a percentage of the 
corresponding hypothetical value at zero time. Vertical bars represent 
the standard errors of means. 
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FIG 2. Half-life (T 1/2) of the lgG-sensitized radiochromated autol-
ogous erythrocytes from the circulation in eleven patients with cuta-
neous vasculitis. The shaded area represents the range ofT 1/ 2 for a 
group of 10 normal subjects (T 1/ 2 = 39 ± 6 min or mean± 2 SD). 
linaemia demonstrated delayed clearance. Indeed, in all the 
patients with these 2 diseases, the rate of clearance of IgG-
sensitized erythrocytes was accelerated (a < 0.01, Fisher's test) 
(T 1/2 = 19 to 29 min). 
In patients with Gougerot-Ruiter's disease, the clearance rate 
was normal in 2 patients, accelerated in 2, and slightly delayed 
in one. 
In the patient with hypergammaglobulinaemic purpura, the 
clearance rate was accelerated (Fig 2) . 
None of the patients who had an acceleration in clearance 
had splenomegaly. 
Simultaneous Measurement of IgG-sensitized 
Radiochromated Erythrocyte Radioactivity in the 
Circulation and over the Liver and Spleen 
Clearance of IgG coated radiochromated erythrocytes in the 
circulation was assessed simultaneously with the determination 
of probe counts over the liver and spleen. This comparison was 
carried out in 5 of the normal controls and 3 of the patients 
(cases 5, 7, and 9). In all the individuals, the clearance was 
mediated by the spleen as shown by the accumulation of 
radioactivity over the spleen (Fig 3). 
Immune Complexes 
The levels of CIC in 11 patients with cutaneous vasculitis and 
in 10 controls who underwent clearance tests are presented in 
Fig 4 and in Table ll. CIC were found in 9 patients, the 
complexes contained C,,, in 9, IgG in 9, IgM in 4 and IgA in 4 . 
The mean value obtained with the pool of 80 normal sera was 
m ± 2 SD (C," = 88 ± 26 J.Lg/rnl, lgG = 48 ± 19 J.Lg/ml and IgM 
= 6E ± 62 J.Lg/rnl) and provided the confidence limits for the 
test. In general, there was a good correlation between our PEG 
assay and the C," binding test (cases 4 and 8). 
Serum IgG, IgM and IgA concentrations were measul'ed and 
could not be statistically correlated with the percentage of 
immunoglobulins precipitated by 2% PEG (Spearman rank 
correlation test) . There was a tendency for patients with slight 
highel' levels of serum IgG to have more PEG-precipitated IgG, 
but the correlation coefficient did not reach statistical correla-
tion (0.05 < oc < 0.06). Serum IgM levels were not correlated 
with PEG-precipitated IgM (0.18 < oc < 0.19) (Table II). 
Correlation of IgG-mediated Clearance and Soluble Immune 
Complexes 
The 2 patients with a normal Fe receptor functional activity 
had high levels of CIC containing C," and lgG (cases 2 and 4) 
(Fig 2 and Table II). Eight of 11 with accelerated clearance 
rates had soluble complexes which had no detectable CIC (case 
1). Thus there was no correlation between accelerated or de-
layed clearance rates and absence or presence of CIC containing 
C,"' IgG, IgM, and IgA. 
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Correlation of !gO-mediated Clearance and Serological 
Studies 
Serum C1,1, Ca, C4, CHso and factor B levels were assayed in 
all t h e patients. Three had depressed levels of at least one of 
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FIG 3. Splenic and hepatic uptake curves for IgG-sensitized radi-
ochromated erythrocytes (A) and corresponding clearance in t he cir-
culation (B) . (Normal control in full line and case 9 in dotted line). 
the complement components. Both CJ and c. or factor B were 
elevated in 2 patients with Gougerot-Ruiter's disease. All the 
patients with low complement component levels had acceler-
ated clearance rates. Seven patients had rheumatoid factor 
(titre range, 1:80 to 1:10, 240). There was no correlation between 
t he rheumatoid factor titre and the clearance rates. 
. DISCUSSION 
Our aim was to study the functional activity of MPS mem-
brane Fe receptors in patients with cutaneous vasculitis. In 
animal experiments, Fe receptors have been shown to mediate 
t he clearance of IgG-containing IC from the circulation [15]. 
Furthermore Haakenstad and Mannik [7] showed that the 
saturation of t hese receptors with large amounts of complexes 
enables the complexes to circulate and consequently to localize 
in t issue sites. Using this model, Frank and Hamburger [8,9] 
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FIG 4. Seru·ch for circulating immune complexes in control sera and 
patient sera. Composition of immune complexes isolated from the era 
of patients with Gougerot-Ruite r's disease e, essential mixed cryoglob-
ulinaemia .A, Waldenstrom's hyperglobulinaemic purpura • and Hen-
och-Schonlein purpura 0. The horizontal bar represents t he upper 
limit of normal values (mean± 2 SD, for 80 normal control subjects) of 
2% PEG precipitated C, ,,, IgG and lgM (% C ," = 88 ± 26ftg/ m1, IgG = 
48 ± 19~-tg/ml and IgM = 68 ± 62~-tg/ml). 
TABLE II. Typ e of PEG-detected circulating immune complexes and relevant laboratory data observed in patients with cutaneous vasculitis 
Type of PEG-detec- Serum immunoglo- Clq- Rheu-
Case ted complex (!'g/ ml) bul in (mg/ ml) bin- mat.oid Complement Diagnos is No. ding factor abnorma lity 
Clq lgG l gM IgA lgG JgM IgA 8S.':U:ly (titre ) % 
Leukocytoclastic vasculitis l 72 65 54 14.5 1.6 3.6 1.87 Normal 
or Gougerot-Ruiter's 2 202 238 105 14.2 1.3 2.8 14.22 1:80 Normal 
disease 3 183 589 149 + 23.7 2.0 9.6 69.86 1:10,240 Low CH50, low C4 
4 130 84 15 11.0 1.4 2.7 ND" High C3, high C4 
5 143 239 54 8.5 0.38 2.7 2.02 Normal 
Essentia l mixed" 6 210 930 305 + 15.5 3.1 2.5 82.30 1:1,280 Low CH50, low C4 
cryoglobulinaemia 7 170 133 134 14.4 0.66 2.0 12.57 1:80 Norma] 
8 133 124 126 11.6 1.2 1.7 ND 1:160 Normal 
Waldenstrom's 9 189 958 149 + 31.0 2.1 1.9 11.94 1:80 Low C3 
hyperglobulinaemic 
purpura 
Henoch-Schonlein 10 / 69 404 126 + 13.7 0.77 3.4 21.08 1:160 Normal 
purpura 11 108 61 54 10.4 1.7 2.3 0.28 Normal 
" ND Not Done 
" The levels of CIC were still superior to normal values after cryoprecipitation for 96 hT, at + 4 °C. 
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suggested that patients with SLE [8] and SS (9] had a defective 
MPS because tissue damage appears to be secondary to IC 
deposition . A saturation by IC or a primary defect in Fc-
receptor function were the most likely explanations to account 
for an inefficient clearance of complexes from the circulation 
leading to a pathological role of IC. These authors evaluated 
the functional status of Fe receptors for IgG antibody in vivo 
by a technique that tests the immunologically specific activity 
of these receptors within the spleen. 
We tried to perform similar technique in order to study 
splenic function of patients with cutaneous vasculitis. A major-
ity of the patients studied had some evidence of CIC. No 
patients were on conventional steroid therapy which could not 
act on the Fe receptor expression. In our own experimental 
conditions, it seemed accepted that the uptake of antibody-
coated erythrocytes was dependent upon Fe receptors of splenic 
macrophages and not hepatic macrophages. 
The major finding to arise from our study is that no signifi-
cant impairment of splenic function was observed in patients 
with cutaneous vasculitis. In contrast, a normal or accelerated 
clearance of IgG-sensitized erythrocytes was found. CIC levels 
obtained by PEG assay or Ct,1 binding assay were not statisti-
cally correlated with clearance rates. One patient showed a 
delayed clearance rate but no circulating soluble IC could be 
detected. There is a contrast between these data and the 
fmdings of Frank et al in SLE [8] where a Fc-receptor defect 
was associated with a high level of CIC and disease activity. 
Why do CIC not block Fey receptors in patients with cutaneous 
vasculitis? We might raise the possibility that the detected CIC 
have a particular composition and biologic properties. Different 
immunoglobulin classes were abnormally found in the PEG-
precipitates. Different factors such as the antibody class, the 
nature of the antigen and the structure of the complexes can 
alter the fate of GIC and influence the activity of immune 
function of the MPS and the clinical manifestations of the 
disease. In fact, Kammer and his colleagues [16] have recently 
presented evidence that patients with cutaneous vasculitis have 
more than one type of IC. These many types of complexes 
possess various properties and are detected by different assays. 
The PEG assay [11] requires complement activation by the 
CIC via the classical pathway, and these complexes theoreti-
cally contain at least antigen, antibody and Ctq· The clearance 
test [8] is independent of complement and strictly deals with 
the functional role of Fey receptors of macrophages and with 
that of the other specific membrane receptors of mononuclear 
phagocytes. For example, the CIC in the patients with an 
accelerated clearance rate might not be sufficiently enrich ed 
with Fe fragments or do not possess sufficient Fe fragments to 
compete with the test particles for the Fey receptors. In Hen-
och-Schonlein it has been proved that IC contained IgA [17] 
but human IgA is ineffective in interacting with the Fe receptors 
of phagocytic cells [18]. 
Additional serological features were examined for their cor-
relation with clearance rates and did not show any noteworthy 
correlation. There were serum complement levels, rheumatoid 
factor titres and serum immunoglobulin concentrations. Al-
though low complement levels coincided with accelerated clear-
ance rates in three patients, a definite interpretation could not 
be broadly claimed. 
According to Frank and his co-workers [8], an accelerated 
Fey-mediated clearance rate could represent the absence of a 
profound defect of splenic Fe receptors. We should not omit 
the hypothetical saturation of other specific membrane recep-
tors of mononuclear phagocytes although our work does not 
present information about on such hypothesis. An identical 
hypothesis was proposed in other diseases such as primary 
biliary cirrhosis and chronic hepatitis or alcoholic cirrhosis 
where patients had high levels of CIC and normal or accelerated 
Fe receptor function [19]. The association of a normal or 
accelerated clearance rate and high levels of CIC can be com-
pared with animal experiments. In animals whose macrophages 
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had been activated by specific immunization, an accelerated 
clearance of IgG-sensitized cells has been reported [20]. In the 
patients studied, the amount of CIC could not be sufficient to 
block Fe receptors but enough to enhance the functional Fe 
receptor activity of the splenic macrophages. 
Recently Hamburger and his colleagues (21] showed a strik-
ing association between the presence of renal disease in patients 
with essential mixed cryoglobulinaemia and a defect of Fe 
receptor activity but failed to show the relationship to the 
amount of cryoglobulins. The behavior of the cryoglobulins 
seems different from that of lgG-coated erythrocytes or partic-
ulate complexes which are taken up by the spleen. Our study 
did not show any association between clearance defect, renal 
disease and CIC levels because none of our patients developed 
renal involvement during their hospitalisation. 
In sum, it is not yet possible to study the in vivo clearance of 
soluble complexes in man. An attempt has been made by Frank 
et ~ [8] and Jaffe et al (19] to understand the impaired 
clearance of ere from the circulation by using particulate 
complexes and testing the functional Fe receptor activity within 
the spleen [8] and c~., receptor activity within the liver [19]. 
Many points are still unclear. Our work showed that no corre-
lation can be easily established between saturation or defect of 
these receptors and the CIC levels although the group studied 
was small and composed of different groups of cutaneous vas-
culitis. Too many factors interfere in the process of clearance. 
Further investigation of the MPS and a better characterization 
of IC composition might explain why CIC persist in the circu-
lation and cause tissue damage and the well-known clinical 
manifestations. 
The authors are grateful to Mrs. M. Bruchon, Mrs. M. Limandas 
and Mrs. M. T. Martin for their excellent technical assistance. 
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